265 related articles for article (PubMed ID: 15661565)
21. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
[TBL] [Abstract][Full Text] [Related]
22. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
23. Is high cord radical orchidectomy always necessary for testicular cancer?
Ashdown DA; Bodiwala D; Liu S
Ann R Coll Surg Engl; 2004 Jul; 86(4):289-91. PubMed ID: 15239874
[TBL] [Abstract][Full Text] [Related]
24. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
25. Paratesticular localization of burned out non-seminomatous germ cell tumor--NSGCT: a case report.
Rzeszutko M; Rzeszutko W; Nienartowicz E; Jeleń M
Pol J Pathol; 2006; 57(1):55-7. PubMed ID: 16739885
[TBL] [Abstract][Full Text] [Related]
26. Clinical study of testicular germ cell tumors.
Tomomasa H; Shimizu H; Sato S; Adachi Y; Ashizawa Y; Kamiyama Y; Okano Y; Sato M; Yoshii T; Iizumi T; Umeda T; Yazaki T
Hinyokika Kiyo; 2001 Jun; 47(6):389-95. PubMed ID: 11496394
[TBL] [Abstract][Full Text] [Related]
27. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
[TBL] [Abstract][Full Text] [Related]
28. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
[TBL] [Abstract][Full Text] [Related]
29. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors.
Gilbert DC; Van As NJ; Huddart RA
Expert Rev Anticancer Ther; 2009 Feb; 9(2):223-33. PubMed ID: 19192960
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment in the management of testis-confined germ cell tumours after orchidectomy.
Sava T; Consoli F; Santo A; Cetto GL
BJU Int; 2008 Jan; 101(2):155-9. PubMed ID: 17662077
[TBL] [Abstract][Full Text] [Related]
31. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
32. Management of stage I testis cancer.
Albers P
Eur Urol; 2007 Jan; 51(1):34-43; discussion 43-4. PubMed ID: 16996677
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
34. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
35. [Medical treatment of metastatic germ cell cancers].
Timsit MO; Lebret T; Lugagne PM; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S376-81. PubMed ID: 19070818
[TBL] [Abstract][Full Text] [Related]
36. Appropriateness of testicular cancer management: a population-based cohort study.
Cheung WY; Demers A; Hossain D; Owen T; Ahmed S; Czaykowski PM
Can J Urol; 2007 Jun; 14(3):3542-50. PubMed ID: 17594744
[TBL] [Abstract][Full Text] [Related]
37. [Metallothionein expression as a marker of therapeutic sensitivity in the early stages of testicular cancer].
Eid H; Institoris E; Bodrogi I; Bak M
Orv Hetil; 1997 Jan; 138(3):135-9. PubMed ID: 9064626
[TBL] [Abstract][Full Text] [Related]
38. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
39. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
40. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]